BiOptic (ROCO:6850) Debt-to-Revenue : 0.37 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is BiOptic Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

BiOptic's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$7.4 Mil. BiOptic's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$85.8 Mil. BiOptic's annualized Revenue for the quarter that ended in Dec. 2023 was NT$251.1 Mil. BiOptic's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.37.

BiOptic Debt-to-Revenue Historical Data

The historical data trend for BiOptic's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BiOptic Debt-to-Revenue Chart

BiOptic Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.89

0.70

0.03

0.06

0.41

BiOptic Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial					0.03	0.06	0.05	0.42	0.37

Competitive Comparison of BiOptic's Debt-to-Revenue

For the Biotechnology subindustry, BiOptic's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BiOptic's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiOptic's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where BiOptic's Debt-to-Revenue falls into.

BiOptic Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

BiOptic's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(7.406	+	85.792)	/	228.269
	=	0.41

BiOptic's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(7.406	+	85.792)	/	251.116
	=	0.37

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

BiOptic Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of BiOptic's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BiOptic (ROCO:6850) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiOptic Inc (ROCO:6850) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 6, Ln, 130 Minquan Road, 5th Floor, Hsin- Tien District, New Taipei, TWN, 23141

Website

https://www.bioptic.com

BiOptic Inc is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry and agriculture, performing diagnostic molecular genetic analyses.

BiOptic (ROCO:6850) Headlines

No Headlines